Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
Clinical trial NCT05683353 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05683353
- Sponsor
- Peking University First Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-14
- Primary completion
- 2025-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.